BioCorRx Reports Business Update for the First Quarter of 2024

May 16, 2024 - BioCorRx Inc. , a developer and provider of innovative treatment programs for substance abuse and related disorders, today provided a business update for the three months ended March...

Related Keywords

United States ,Japan ,Lourdes Felix ,Kate Beebe Devarney ,National Institutes Of Health Under Award Number ,Agreement Terms ,End Addiction Initiative ,Development Of Medications To ,Exchange Commission ,Biocorrx Pharmaceuticals Board Of Directors ,National Institute On Drug Abuse ,Biocorrx Inc ,Biocorrx Pharmaceuticals ,National Institutes Of Health ,Trademark Office ,National Survey On Drug ,Biocorrx Pharmaceuticals Inc ,Uncraverx Weight Loss Program ,Corrx Inc ,Corrx Pharmaceuticals ,Drug Abuse ,Beebe Devarney ,Biocorrx Pharmaceuticals Board ,United States Patent ,Opioid Use Disorder ,Corrx Pharmaceuticals Inc ,End Addiction Long Term Initiative ,Cooperative Agreement Terms ,Treat Opioid Use Disorders ,Clinical Trial Optional ,Institute On Drug Abuse ,Drug Use ,Addiction Recovery ,Cognitive Behavioral Therapy ,Japan Corporate News ,